Literature DB >> 25712009

CRHR1 Gene SNPs and Response to Systemic Corticosteroids in Indian Asthmatic Children During Acute Exacerbation.

Shally Awasthi1, Sarika Gupta, Sarita Agarwal, Neeraj Sharma.   

Abstract

OBJECTIVE: To determine association of corticotrophin releasing hormone receptor 1 (CRHR1) gene single nucleotide polymorphisms (SNPs), rs242939 (A>G) and rs242941 (G>T) with response to systemic corticosteroids in North Indian asthmatic children during acute exacerbation.
METHODS: This was a hospital based cross-sectional study. Sixty-eight children aged 1 to 12 y with acute exacerbation of asthma were included in the study. The study was approved by the institutional ethics committee and written informed consent was obtained from parents/guardians of recruited children. GINA guidelines 2008, were used for classification and treatment of acute exacerbation of asthma. As per the GINA guidelines 2008, children who had good response to injectable corticosteroid were classified as "Corticosteroid Responders" (CR). Rest of the children with incomplete or poor response to injectable corticosteroid were classified as "Corticosteroid Non Responders" (CNR).
RESULTS: Among 68 hospitalized children, 45 (66.17 %) children were CR whereas 23 (33.83 %) children were CNR. On analyzing as dominant model, children with one or two copies of mutant allele of SNP rs242941 had statistically significant better response to systemic corticosteroid (OR = 5.00; 95 %CI = 1.32-19.64; p 0.013) as compared to children with no mutant allele.
CONCLUSIONS: Thus, CRHR1 gene SNP rs242941 polymorphism is associated with better response to systemic corticosteroid during acute exacerbation of asthma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712009     DOI: 10.1007/s12098-015-1702-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  23 in total

1.  Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Authors:  D R Taylor; J M Drazen; G P Herbison; C N Yandava; R J Hancox; G I Town
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 2.  Asthma.

Authors:  A E Tattersfield; A J Knox; J R Britton; I P Hall
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

3.  Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.

Authors:  M Sauvage; T Steckler
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms.

Authors:  Antoon Dijkstra; Gerard H Koppelman; Judith M Vonk; Marcel Bruinenberg; Jan P Schouten; Dirkje S Postma
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

5.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

6.  Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.

Authors:  J M Drazen; C N Yandava; L Dubé; N Szczerback; R Hippensteel; A Pillari; E Israel; N Schork; E S Silverman; D A Katz; J Drajesk
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

7.  Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Authors:  K H In; K Asano; D Beier; J Grobholz; P W Finn; E K Silverman; E S Silverman; T Collins; A R Fischer; T P Keith; K Serino; S W Kim; G T De Sanctis; C Yandava; A Pillari; P Rubin; J Kemp; E Israel; W Busse; D Ledford; J J Murray; A Segal; D Tinkleman; J M Drazen
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma.

Authors:  P Christodoulopoulos; D Y Leung; M W Elliott; J C Hogg; S Muro; M Toda; S Laberge; Q A Hamid
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

Review 9.  Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects.

Authors:  I J Elenkov; E L Webster; D J Torpy; G P Chrousos
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

10.  Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.

Authors:  Woo J Kim; Seung S Sheen; Tae-Hyung Kim; Jin W Huh; Ji-Hyun Lee; Eun-Kyung Kim; Jin H Lee; Sang-Min Lee; Sangyeub Lee; Seong Y Lim; Tae R Shin; Ho I Yoon; Yeon-Mok Oh; Sang D Lee
Journal:  Respirology       Date:  2008-12-11       Impact factor: 6.424

View more
  3 in total

1.  Pharmacogenetics of Asthma.

Authors:  Puneet Kaur Sahi; Neerja Gupta
Journal:  Indian J Pediatr       Date:  2015-07-07       Impact factor: 1.967

2.  PTGDR gene expression and response to dexamethasone treatment in an in vitro model.

Authors:  Elena Marcos-Vadillo; Asunción García-Sánchez; Catalina Sanz; Ignacio Davila; María Isidoro-García
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 3.  Genetic Mechanisms of Asthma and the Implications for Drug Repositioning.

Authors:  Yue Huo; Hong-Yu Zhang
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.